chartexchange

RIVERMARK MEDICAL COMPLETES ENROLLMENT IN RAPID III PIVOTAL STUDY OF THE FLOSTENT™ SYSTEM AND STRENGTHENS LEADERSHIP WITH TWO KEY APPOINTMENTS

PR Newswire | Nov 17, 2026 9:09 AM EST

Urology industry veteran Steve Blum joins Board of Directors; Axonics co-founder and former CEO Raymond W. Cohen named Senior Advisor MILWAUKEE, Nov. 17, 2026 /PRNewswire/ -- Rivermark Medical, a medical device company developing innovative treatments for benign prostatic hyperplasia...

Read original article